FDA requires lower doses for sleep medications

FDA requires lower doses for sleep medications

Posted: Updated:
This file product image provided by Meda Pharmaceuticals shows packages of Edluar, a sleep medication that contains the drug zolpidem. (AP Photo/Meda Pharmaceuticals) This file product image provided by Meda Pharmaceuticals shows packages of Edluar, a sleep medication that contains the drug zolpidem. (AP Photo/Meda Pharmaceuticals)

WASHINGTON (AP) -- The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.

The agency says new research shows that the widely-used sleeping drugs remain in the blood at levels high enough to interfere with driving, which increases the risk of car accidents.

Regulators are ordering drug manufacturers to cut the dose of the medications in half for women, who process the drug more slowly. The FDA is also recommending that manufacturers use the lower doses for men, though it will not be mandatory.

The new doses apply to all insomnia treatments containing the drug zolpidem, which is sold under the brands Ambien, Edluar and Zolpimist.

  • HealthMore>>

  • Teen caught urinating in reservoir

    Teen caught urinating in reservoir

    Wednesday, April 16 2014 6:04 PM EDT2014-04-16 22:04:13 GMT
    Once again, Portland officials are preparing to flush millions of gallons of treated water because a young person urinated into a city reservoir.  Water Bureau Administrator David Shaff said 38 million gallons will be discarded because a 19-year-old was caught in the act on Wednesday.
    Once again, Portland officials are preparing to flush millions of gallons of treated water because a young person urinated into a city reservoir.  Water Bureau Administrator David Shaff said 38 million gallons will be discarded because a 19-year-old was caught in the act on Wednesday.
  • Allergy season expected to be bad

    Allergy season expected to be bad

    Wednesday, April 16 2014 6:56 AM EDT2014-04-16 10:56:12 GMT
    There is not much relief in sight for allergy sufferers. Experts say a shortened spring due to the long winter may create a more intense allergy season.  Some allergists say they've already seen a noticeable increase in patients as the weather has gotten warmer.
    There is not much relief in sight for allergy sufferers. Experts say a shortened spring due to the long winter may create a more intense allergy season.  Some allergists say they've already seen a noticeable increase in patients as the weather has gotten warmer.
  • FDA's warning letter to maker of controversial supplement Craze

    FDA's warning letter to maker of controversial supplement Craze

    Tuesday, April 15 2014 10:38 PM EDT2014-04-16 02:38:33 GMT
    A report first surfaced last year about meth-like substances in Craze. The product was immediately pulled from the shelves of many major retailers, including Walmart. Now the federal government is taking its first action against the company behind the product. The supplement Craze was marketed as a product offering endless energy, a preworkout supplement popular with body builders. But a warning letter from the FDA confirms what Harvard scientists have previously alleged.
    A report first surfaced last year about meth-like substances in Craze. The product was immediately pulled from the shelves of many major retailers, including Walmart. Now the federal government is taking its first action against the company behind the product. The supplement Craze was marketed as a product offering endless energy, a preworkout supplement popular with body builders. But a warning letter from the FDA confirms what Harvard scientists have previously alleged.
Powered by WorldNow

KTBC FOX 7
119 East 10th Street
Austin, TX 78701

Phone: (512) 476-7777
Fax: (512) 495-7001

Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | Terms of Service | Ad Choices